Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Lixisenatide inhibits the inflammatory response through down regulation of pro-inflammatory cytokines, and suppresses of the Akt-MEK1/2 signaling pathway. Lixisenatide can inhibit oxidative stress, mitochondrial dysfunction and apoptosis. Lixisenatide can be used for the researches of inflammation, metabolic disease, neurological disease and cardiovascular disease, such as rheumatoid arthritis, diabetes, Alzheimers disease and atherosclerosis[1][2][3][4][5][6].
Molecular Weight:
4858.49
Purity:
99.93
CAS Number:
[320367-13-3]
Formula:
C215H347N61O65S
Target:
Akt,Apoptosis,GLP Receptor,MEK,MMP,Reactive Oxygen Species (ROS)
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
